Apnission

Apnission may be available in the countries listed below.

Ingredient matches for Apnission

Aminophylline

Aminophylline is reported as an ingredient of Apnission in the following countries:

• Japan

International Drug Name Search

Risperidon axcount

Risperidon axcount may be available in the countries listed below.

Ingredient matches for Risperidon axcount

Risperidone

Risperidone is reported as an ingredient of Risperidon axcount in the following countries:

• Germany

International Drug Name Search

Maintane Tab.

Maintane Tab. may be available in the countries listed below.

Ingredient matches for Maintane Tab.

Allylestrenol

Allylestrenol is reported as an ingredient of Maintane Tab. in the following countries:

• India

International Drug Name Search

Sim 12

Sim 12 may be available in the countries listed below.

Ingredient matches for Sim 12

Cobamamide

Cobamamide is reported as an ingredient of Sim 12 in the following countries:

• Peru

International Drug Name Search

Ezede

Ezede may be available in the countries listed below.

Ingredient matches for Ezede

Loratadine

Loratadine is reported as an ingredient of Ezede in the following countries:

• Hong Kong


• Myanmar


• Singapore


• Sri Lanka

International Drug Name Search

Erasef

Erasef may be available in the countries listed below.

Ingredient matches for Erasef

Cefprozil

Cefprozil is reported as an ingredient of Erasef in the following countries:

• Turkey

International Drug Name Search

Arimidex

In the US, Arimidex (anastrozole systemic) is a member of the following drug classes: aromatase inhibitors, hormones/antineoplastics and is used to treat Breast Cancer, Breast Cancer - Metastatic, McCune-Albright Syndrome and Pubertal Gynecomastia.

US matches:

• Arimidex

UK matches:

• Arimidex 1mg Film-Coated Tablet
• Arimidex 1mg Film-Coated Tablet (SPC)

Ingredient matches for Arimidex

Anastrozole

Anastrozole is reported as an ingredient of Arimidex in the following countries:

• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Bahrain


• Belarus


• Belgium


• Bermuda


• Bolivia


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Cambodia


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• Egypt


• El Salvador


• Estonia


• Finland


• France


• Georgia


• Germany


• Ghana


• Greece


• Guatemala


• Guyana


• Haiti


• Honduras


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Jordan


• Kazakhstan


• Kenya


• Kuwait


• Latvia


• Lebanon


• Libya


• Lithuania


• Luxembourg


• Macedonia


• Malawi


• Malaysia


• Malta


• Mexico


• Mozambique


• Netherlands


• Netherlands Antilles


• New Zealand


• Nicaragua


• Nigeria


• Norway


• Oman


• Pakistan


• Panama


• Paraguay


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• South Korea


• Spain


• Sri Lanka


• Sudan


• Sweden


• Switzerland


• Syria


• Taiwan


• Tanzania


• Thailand


• Trinidad & Tobago


• Tunisia


• Turkey


• Uganda


• Ukraine


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Venezuela


• Vietnam


• Yemen


• Zambia


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Magnerot N

Magnerot N may be available in the countries listed below.

Ingredient matches for Magnerot N

Magnesium

Magnesium mixture of several salts (a derivative of Magnesium) is reported as an ingredient of Magnerot N in the following countries:

• Germany

International Drug Name Search

Telebrix Sodium

Telebrix Sodium may be available in the countries listed below.

Ingredient matches for Telebrix Sodium

Ioxitalamic Acid

Ioxitalamic Acid sodium salt (a derivative of Ioxitalamic Acid) is reported as an ingredient of Telebrix Sodium in the following countries:

• Israel


• Luxembourg


• Portugal

International Drug Name Search

Onxol

Pronunciation: PAK-li-TAX-el
Generic Name: Paclitaxel
Brand Name: Generic only. No brands available.

Onxol must be administered in an appropriate medical setting. Serious allergic reactions, some fatal, have occurred with the use of Onxol. DO NOT use Onxol again if you have experienced a severe allergic reaction to it. Stop using Onxol and notify your doctor immediately if you develop signs of an allergic reaction, such as rash; itching; fainting; severe dizziness or light-headedness; swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness.

Certain patients with solid tumors or AIDS-related Kaposi sarcoma should not use Onxol. Frequent blood tests should be performed while you are using Onxol because of the risk of bone marrow suppression and serious infection.

Do not substitute or interchange Onxol with other forms of paclitaxel.

Onxol is used for:

Treating certain types of ovarian, lung, or breast cancer in certain patients. It is also used to treat AIDS-related Kaposi sarcoma in certain patients. It may also be used for other types of cancers as determined by your doctor.

Onxol is a chemotherapy medicine. It works by slowing or stopping cancer cells from dividing and growing, so they eventually die.

Do NOT use Onxol if:

• you are allergic to any ingredient in Onxol or medicines that contain polyoxyethylated castor oil (eg, cyclosporine injection, teniposide injection)


• you have extremely low white blood cell counts (eg, extremely low neutrophil counts)


• you have shingles or chickenpox

Contact your doctor or health care provider right away if any of these apply to you.

Before using Onxol:

Some medical conditions may interact with Onxol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a bacterial or viral infection, or HIV infection


• if you have a history of a heart attack or other heart problems (eg, irregular heartbeat), high or low blood pressure, liver or kidney problems, bone marrow problems, or blood problems (eg, low blood platelet or neutrophil counts)


• if you are undergoing radiation therapy


• if you have ever had an allergic reaction to an insect sting

Some MEDICINES MAY INTERACT with Onxol. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Azole antifungals (eg, itraconazole, ketoconazole), benzodiazepines (eg, midazolam, triazolam), buspirone, cimetidine, cisplatin, eletriptan, felodipine, fluoxetine, gemfibrozil, HIV protease inhibitors (eg, indinavir, ritonavir), HMG-CoA reductase inhibitors (eg, lovastatin, simvastatin), macrolides (eg, clarithromycin, erythromycin), nefazodone, repaglinide, rosiglitazone, sildenafil, or telithromycin because they may increase the risk of Onxol's side effects


• Carbamazepine, efavirenz, nevirapine, phenytoin, or rifampin because they may decrease Onxol's effectiveness


• Anticoagulants (eg, warfarin) or doxorubicin because the risk of their side effects may be increased by Onxol

This may not be a complete list of all interactions that may occur. Ask your health care provider if Onxol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Onxol:

Use Onxol as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Onxol. Talk to your pharmacist if you have questions about this information.


• Onxol is usually given as an injection at your doctor's office, hospital, or clinic. Contact your health care provider if you have any questions.


• If nausea, vomiting, diarrhea, or loss of appetite occurs, do not discontinue your medicine. Ask your doctor or pharmacist for ways to lessen these effects.


• You should receive certain other medicines, such as corticosteroids (eg, prednisone), diphenhydramine, and H₂ blocker (eg, famotidine), before each treatment with Onxol to decrease the chance of an allergic reaction. Discuss any questions with your doctor.


• Wear gloves while handling Onxol.


• If you get Onxol on your skin, rinse the area thoroughly with soap and water. If you get Onxol in your eyes, nose, or mouth, flush the area thoroughly with water.


• If you miss a dose of Onxol, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Onxol.

Important safety information:

• Serious allergic reactions, some fatal, have occurred with the use of Onxol. You will need to take certain other medicines before using Onxol in order to lessen the risk of having an allergic reaction. Stop using Onxol and notify your doctor immediately if you develop signs of an allergic reaction, such as rash; itching; severe dizziness or light-headedness; swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness.


• Some patients develop redness or sores in the mouth or on the lips. These symptoms may occur a few days after treatment with Onxol and usually decrease or disappear in 1 week. Talk with your doctor about proper mouth care and other ways to prevent or reduce this side effect.


• Onxol may cause dizziness or vision changes. These effects may be worse if you take it with alcohol or certain medicines. Use Onxol with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Onxol has alcohol in it and may interact with other medicines. Alcohol in drinks or other medicines may increase the effects of Onxol. Before you start any new medicine, check the label to see if it has alcohol in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Onxol may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• Onxol may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.


• If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.


• Talk with your doctor before you receive any vaccine.


• Tell your doctor or dentist that you take Onxol before you receive any medical or dental care, emergency care, or surgery.


• Lab tests, including complete blood cell counts, vital signs (such as pulse and blood pressure), and liver function, may be performed while you use Onxol. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Onxol with caution in the ELDERLY; they may be more sensitive to its effects, especially effects on the bone marrow (myelosuppression), nerve problems, or heart problems.


• Onxol should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• Women who may become pregnant should use effective birth control (eg, condoms) while using Onxol. Talk with your doctor if you have questions about effective birth control.


• Men who use Onxol should talk with their doctor about the use of effective birth control when having sex with a woman who may become pregnant.


• PREGNANCY AND BREAST-FEEDING: Onxol has been shown to cause harm to the fetus. Avoid becoming pregnant while you are using it. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Onxol while you are pregnant. It is not known if Onxol is found in breast milk. Do not breast-feed while using Onxol.

Possible side effects of Onxol:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Cough; diarrhea; general feeling of discomfort; hair loss; mild discomfort, redness, or swelling at the injection site; mild joint or muscle pain; nausea; numbness, tingling, or burning of the arms, hands, legs, or feet; redness and/or sores on the mouth or lips; weakness or tiredness; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; flushing; swelling of the mouth, face, lips, tongue, or throat; hoarseness); blistering, swelling, redness, severe pain, or open sores on your skin or at the injection site; calf or leg redness, swelling, pain, or tenderness; change in the amount of urine produced; chest pain; fainting; fast, slow, or irregular heartbeat; hearing trouble or loss of hearing; pale appearance; ringing in the ears; seizures; severe or persistent joint or muscle pain; severe or persistent nausea, vomiting, or diarrhea; severe or persistent numbness, tingling, or burning in the arms, hands, legs, or feet; severe or persistent stomach pain; sudden or severe dizziness, light-headedness, or headache; swelling of the arms, hands, legs, or feet; symptoms of infection (eg, fever, chills, sore throat); symptoms of liver problems (eg, dark urine, pale stools, persistent loss of appetite, yellowing of the skin or eyes); unusual bruising or bleeding; unusual tiredness or weakness; vision changes (eg, blurred vision).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Onxol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include burning, numbness, or tingling; redness and/or sores on the mouth or lips; symptoms of infection (eg, fever, chills, persistent sore throat); unusual bruising or bleeding; unusual tiredness or weakness.

Proper storage of Onxol:

Store Onxol as directed on the prescription label. Keep Onxol out of the reach of children and away from pets.

General information:

• If you have any questions about Onxol, please talk with your doctor, pharmacist, or other health care provider.


• Onxol is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Onxol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Onxol resources

• Onxol Side Effects (in more detail)
• Onxol Use in Pregnancy & Breastfeeding
• Onxol Drug Interactions
• Onxol Support Group
• 0 Reviews for Onxol - Add your own review/rating

• Onxol Prescribing Information (FDA)


• Onxol Advanced Consumer (Micromedex) - Includes Dosage Information


• Paclitaxel Prescribing Information (FDA)


• Paclitaxel Professional Patient Advice (Wolters Kluwer)


• Paclitaxel Monograph (AHFS DI)


• Taxol Prescribing Information (FDA)


• Taxol Consumer Overview

Compare Onxol with other medications

• Breast Cancer
• Breast Cancer, Adjuvant
• Breast Cancer, Metastatic
• Kaposi's Sarcoma
• Non-Small Cell Lung Cancer
• Ovarian Cancer
• Wilms' Tumor

Sulamine

Sulamine may be available in the countries listed below.

Ingredient matches for Sulamine

Doxylamine

Doxylamine succinate (a derivative of Doxylamine) is reported as an ingredient of Sulamine in the following countries:

• Algeria

International Drug Name Search

Ranix

Ranix may be available in the countries listed below.

Ingredient matches for Ranix

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranix in the following countries:

• Bangladesh


• Croatia (Hrvatska)

International Drug Name Search